A Retrospective Study on the Combined Biomarkers and Ratios in Serum and Pleural Fluid to Distinguish the Multiple Types of Pleural Effusion

Overview

Journal BMC Pulm Med

Publisher Biomed Central

Specialty Pulmonary Medicine

Date 2021 Mar 20

PMID 33740937

Citations 9

Authors

Liyan Lin

Shuguang Li

Qiao Xiong

Hui Wang

Affiliations

Soon will be listed here.

Abstract

Purpose: Pleural effusion (PE) is a common clinical manifestation, and millions of people suffer from pleural disease. Herein, this retrospective study was performed to evaluate the biomarkers and ratios in serum and pleural fluid (PF) for the differential diagnosis of the multiple types of PE and search for a new diagnostic strategy for PE.

Methods: In-patients, who developed tuberculous PE (TPE), malignant PE (MPE), complicated parapneumonic effusion (CPPE), uncomplicated PPE (UPPE), or PE caused by connective tissue diseases (CTDs) and underwent thoracentesis at Peking University People's Hospital from November 2016 to April 2019, were included in this study. Eleven biomarkers and their ratios in serum and PF were investigated and compared between pairs of the different PE groups, and a decision-tree was developed.

Results: Totally 112 PE cases, including 25 MPE, 33 TPE, 19 CPPE, 27 UPPE, and 8 PE caused by CTDs, were reviewed. Biomarkers and ratios showed good diagnostic performance with high area under the curve values, sensitivities, and specificities for the differential diagnosis of the multiple types of PE. According to the decision-tree analysis, the combination of adenosine deaminase (ADA), serum albumin, serum lactate dehydrogenase, total protein, PF-LDH/ADA, and PF-LDH/TP provided the best predictive capacity with an overall accuracy of 84.8%; the sensitivity and specificity for TPE diagnosis were 100% and 98.7%, respectively.

Conclusion: The biomarkers and ratios showed good diagnostic performance, and a decision-tree with an overall accuracy of 84.8% was developed to differentiate the five types of PE in clinical settings.

Citing Articles

Host blood protein biomarkers to screen for tuberculosis disease: a systematic review and meta-analysis.

Gaeddert M, Glaser K, Chendi B, Sultanli A, Koeppel L, MacLean E J Clin Microbiol. 2024; 62(11):e0078624.

PMID: 39445833 PMC: 11559064. DOI: 10.1128/jcm.00786-24.

The diagnostic value and validation of IL-22 combimed with sCD40L in tuberculosis pleural effusion.

Xu Y, Wu J, Yao Q, Liu Q, Chen H, Zhang B BMC Immunol. 2024; 25(1):66.

PMID: 39385103 PMC: 11463108. DOI: 10.1186/s12865-024-00652-w.

Performance verification of a biochemical detection system for hydrothorax and ascites and clinical diagnostic accuracy evaluation of exudate and tuberculous effusion.

Huang J, Feng P, Chen Y, Li X, Izevbaye I, Lu W J Thorac Dis. 2024; 16(5):3350-3360.

PMID: 38883656 PMC: 11170375. DOI: 10.21037/jtd-24-345.

Clinical significance of pleural fluid lactate dehydrogenase/adenosine deaminase ratio in the diagnosis of tuberculous pleural effusion.

Zhao T, Zhang J, Zhang X, Wang C BMC Pulm Med. 2024; 24(1):241.

PMID: 38750432 PMC: 11097553. DOI: 10.1186/s12890-024-03055-0.

ADA as main biochemical marker in patients with tuberculous effusion.

Jankovic J, Ilic B, durdevic N, Jandric A J Med Biochem. 2023; 42(4):722-726.

PMID: 38084235 PMC: 10710802. DOI: 10.5937/jomb0-44018.

References

Aggarwal A, Agarwal R, Sehgal I, Dhooria S . Adenosine deaminase for diagnosis of tuberculous pleural effusion: A systematic review and meta-analysis. PLoS One. 2019; 14(3):e0213728. PMC: 6435228. DOI: 10.1371/journal.pone.0213728. View

Choi B, Yoon M, Shin K, Lee Y, Song Y . Characteristics of pleural effusions in systemic lupus erythematosus: differential diagnosis of lupus pleuritis. Lupus. 2014; 24(3):321-6. DOI: 10.1177/0961203314555171. View

Koegelenberg C, Diacon A, Bolliger C . Parapneumonic pleural effusion and empyema. Respiration. 2008; 75(3):241-50. DOI: 10.1159/000117172. View

Feller-Kopman D, Light R . Pleural Disease. N Engl J Med. 2018; 378(8):740-751. DOI: 10.1056/NEJMra1403503. View

Zhang F, Hu L, Wang J, Chen J, Chen J, Wang Y . Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion. J Clin Lab Anal. 2016; 31(5). PMC: 6817298. DOI: 10.1002/jcla.22106. View

Chen K, Feng P, Chang C, Chen T, Chuang H, Lee C . Novel biomarker analysis of pleural effusion enhances differentiation of tuberculous from malignant pleural effusion. Int J Gen Med. 2016; 9:183-9. PMC: 4910680. DOI: 10.2147/IJGM.S100237. View

Porcel J . Biomarkers in the diagnosis of pleural diseases: a 2018 update. Ther Adv Respir Dis. 2018; 12:1753466618808660. PMC: 6204620. DOI: 10.1177/1753466618808660. View

Lee J, Yoo S, Lee S, Cha S, Park J, Kim C . Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels. Infection. 2016; 45(1):59-65. DOI: 10.1007/s15010-016-0928-5. View

Kronbichler A, Kerschbaum J, Grundlinger G, Leierer J, Mayer G, Rudnicki M . Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis. Nephrol Dial Transplant. 2015; 31(6):930-6. DOI: 10.1093/ndt/gfv336. View

10.

Shaw M, Collins B, Ho L, Raghu G . Rheumatoid arthritis-associated lung disease. Eur Respir Rev. 2015; 24(135):1-16. PMC: 9487778. DOI: 10.1183/09059180.00008014. View

11.

Vitali C, Bombardieri S, Jonsson R, Moutsopoulos H, Alexander E, Carsons S . Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002; 61(6):554-8. PMC: 1754137. DOI: 10.1136/ard.61.6.554. View

12.

Perez-Rodriguez E, Jimenez Castro D . The use of adenosine deaminase and adenosine deaminase isoenzymes in the diagnosis of tuberculous pleuritis. Curr Opin Pulm Med. 2000; 6(4):259-66. DOI: 10.1097/00063198-200007000-00002. View

13.

Liu Y, Ou Q, Zheng J, Shen L, Zhang B, Weng X . A combination of the QuantiFERON-TB Gold In-Tube assay and the detection of adenosine deaminase improves the diagnosis of tuberculous pleural effusion. Emerg Microbes Infect. 2016; 5(8):e83. PMC: 5034099. DOI: 10.1038/emi.2016.80. View

14.

Verma A, Abisheganaden J, Light R . Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio). Lung. 2015; 194(1):147-53. PMC: 4740559. DOI: 10.1007/s00408-015-9831-6. View

15.

Saraya T, Ohkuma K, Koide T, Goto H, Takizawa H, Light R . A novel diagnostic method for distinguishing parapneumonic effusion and empyema from other diseases by using the pleural lactate dehydrogenase to adenosine deaminase ratio and carcinoembryonic antigen levels. Medicine (Baltimore). 2019; 98(13):e15003. PMC: 6456121. DOI: 10.1097/MD.0000000000015003. View

16.

Koppurapu V, Meena N . A review of the management of complex para-pneumonic effusion in adults. J Thorac Dis. 2017; 9(7):2135-2141. PMC: 5542983. DOI: 10.21037/jtd.2017.06.21. View

17.

Coppalle S, Rave G, Abderrahman A, Ali A, Salhi I, Zouita S . Relationship of Pre-season Training Load With In-Season Biochemical Markers, Injuries and Performance in Professional Soccer Players. Front Physiol. 2019; 10:409. PMC: 6474299. DOI: 10.3389/fphys.2019.00409. View

18.

Sahn S, Huggins J, San Jose M, Alvarez-Dobano J, Valdes L . Can tuberculous pleural effusions be diagnosed by pleural fluid analysis alone?. Int J Tuberc Lung Dis. 2013; 17(6):787-93. DOI: 10.5588/ijtld.12.0892. View

19.

Verma A, Phua C, Sim W, Algoso R, Tee K, Lew S . Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion. Medicine (Baltimore). 2016; 95(26):e3996. PMC: 4937920. DOI: 10.1097/MD.0000000000003996. View

20.

Porcel J . Distinguishing complicated from uncomplicated parapneumonic effusions. Curr Opin Pulm Med. 2015; 21(4):346-51. DOI: 10.1097/MCP.0000000000000164. View